The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Bradley S. Galer
Endo Pharmaceuticals
Inc., Clinical Development
100 Endo Blvd.
USA
Name/email consistency: high
- MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Galer, B.S., Lee, D., Ma, T., Nagle, B., Schlagheck, T.G. Pain (2005)
- Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Galer, B.S., Sheldon, E., Patel, N., Codding, C., Burch, F., Gammaitoni, A.R. Curr. Med. Res. Opin (2004)
- Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Galer, B.S., Gammaitoni, A.R., Oleka, N., Jensen, M.P., Argoff, C.E. Curr. Med. Res. Opin (2004)
- The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Galer, B.S., Jensen, M.P., Ma, T., Davies, P.S., Rowbotham, M.C. Clin. J. Pain (2002)
